Junji Tanaka

4PUBLICATIONS
10CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Adolescent healthHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 06, 2024
Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes.

Yan-Hua Wang, Shotaro Hagiwara, Hiroshi Kazama

|Apr 08, 2022
The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation.

Yutaka Shimazu, Makoto Murata, Takeshi Kondo

|Feb 25, 2022
Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation.

Hisashi Ishida, Motohiro Kato, Yuta Kawahara

|Sep 09, 2020
Recent advances in chimeric antigen receptor natural killer cell therapy for overcoming intractable hematological malignancies.

Junji Tanaka

Pageof 1

Frequent Collaborators

1 joint publications

Hisashi Ishida

1 joint publications

Yuta Kawahara

1 joint publications

Shinichi Kako

1 joint publications

Mitsuteru Hiwatari